Cargando…

Innovative drug development for headache disorders /

Migraine treatment improved considerably with the advent of the 'triptans' in the 1990s. While the drugs used previously for headache treatment had efficacy, some compounds had bothersome side effects and their overuse could lead to severe complications. In the early days of the triptans,...

Descripción completa

Detalles Bibliográficos
Clasificación:Libro Electrónico
Otros Autores: Olesen, Jes, Ramadan, Nabih
Formato: Electrónico eBook
Idioma:Inglés
Publicado: Oxford ; New York : Oxford University Press, 2008.
Colección:Frontiers in headache research ; v. 16.
Temas:
Acceso en línea:Texto completo

MARC

LEADER 00000cam a2200000 a 4500
001 EBSCO_ocn801404391
003 OCoLC
005 20231017213018.0
006 m o d
007 cr cnu---unuuu
008 120723s2008 enka ob 001 0 eng d
010 |z  2008021573 
040 |a N$T  |b eng  |e pn  |c N$T  |d E7B  |d OCLCQ  |d OCLCF  |d NLGGC  |d YDXCP  |d EBLCP  |d IDEBK  |d OCLCQ  |d STBDS  |d TOA  |d AGLDB  |d OCLCO  |d OCLCQ  |d OCLCA  |d STF  |d OCLCO  |d VNS  |d VTS  |d REC  |d OCLCQ  |d OCLCO  |d OCLCQ  |d OCLCA  |d AJS  |d OCLCQ  |d OCLCO  |d INARC  |d OCLCO  |d OCLCQ 
015 |a GBA889279  |2 bnb 
016 7 |a 101474374  |2 DNLM 
016 7 |a 014669623  |2 Uk 
019 |a 801363524  |a 1302077418 
020 |a 9780191564628  |q (electronic bk.) 
020 |a 0191564621  |q (electronic bk.) 
020 |z 9780199552764 
020 |z 0199552762 
029 1 |a AU@  |b 000051583918 
029 1 |a AU@  |b 000062594391 
029 1 |a DEBBG  |b BV043157840 
029 1 |a DEBSZ  |b 421394722 
035 |a (OCoLC)801404391  |z (OCoLC)801363524  |z (OCoLC)1302077418 
050 4 |a RC392  |b .I558 2008eb 
060 4 |a W1  |b FR945YD v.16 2008 
060 4 |a WL 342  |b I58 2008 
072 7 |a HEA  |x 039110  |2 bisacsh 
072 7 |a MED  |x 056000  |2 bisacsh 
082 0 4 |a 616.8/491061  |2 22 
049 |a UAMI 
245 0 0 |a Innovative drug development for headache disorders /  |c edited by Jes Olesen, Nabih Ramadan. 
260 |a Oxford ;  |a New York :  |b Oxford University Press,  |c 2008. 
300 |a 1 online resource (xii, 227 pages) :  |b illustrations 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
490 1 |a Frontiers in headache research series ;  |v v. 16 
504 |a Includes bibliographical references and index. 
505 0 |a Effectiveness of different steroid dosage in Tolosa-Hunt syndrome with different phenotypes: some critical points about the new International Headache Society classification / E. Marchioni [and others] -- Discussion summary: trial methodology / Jes Olesen -- Inducible nitric oxide synthase and development of new migraine treatments / Boris A. Chizh -- Mechanisms of cortical spreading depression as targets for migraine therapy / Kevin C. Brennan and Andrew C. Charles -- Tonabersat / Peter R. Blower and Paul C. Sharpe -- Discussion summary: nitric oxide and spreading depression modulators / Nabih Ramadan -- Calcitonin gene-related peptide: relevance for migraine / Jes Olesen and Inger Jansen-Olesen. 
505 0 |a KATP channels and migraine / Inger Jansen-Olesen and Kenneth Beri Ploug -- Antiepileptic drugs and migraine / Michael A. Rogawski -- Discussion summary : ion channel modulators and antiepileptics / Pramod R. Saxena -- Innovative drug development for headache disorders : glutamate / Kirk W. Johnson [and others] -- The modulation of TRPV1 channels by cannabinoid1 receptors / Beatriz Fioravanti and Todd W. Vanderah -- Future targets for headache therapy: prostanoids / Christian Waeber -- Role of anandamide in the modulation of nitroglycerin-induced hyperalgesia: a study in the rat / Cristina Tassorelli [and others]. 
588 0 |a Print version record. 
520 |a Migraine treatment improved considerably with the advent of the 'triptans' in the 1990s. While the drugs used previously for headache treatment had efficacy, some compounds had bothersome side effects and their overuse could lead to severe complications. In the early days of the triptans, it was widely presumed that migraine was no longer a treatment problem. However, it has gradually been recognized that a significant proportion of patients are not responsive to triptans or do not tolerate them. 
590 |a eBooks on EBSCOhost  |b EBSCO eBook Subscription Academic Collection - Worldwide 
650 0 |a Headache  |x Chemotherapy. 
650 0 |a Analgesics. 
650 0 |a Drug development. 
650 1 2 |a Headache Disorders  |x drug therapy 
650 2 2 |a Headache Disorders  |x prevention & control 
650 2 |a Analgesics 
650 6 |a Céphalée  |x Chimiothérapie. 
650 6 |a Analgésiques. 
650 6 |a Médicaments  |x Développement. 
650 7 |a HEALTH & FITNESS  |x Diseases  |x Nervous System (incl. Brain)  |2 bisacsh 
650 7 |a MEDICAL  |x Neurology.  |2 bisacsh 
650 7 |a Analgesics.  |2 fast  |0 (OCoLC)fst00808271 
650 7 |a Drug development.  |2 fast  |0 (OCoLC)fst00898670 
650 7 |a Headache  |x Chemotherapy.  |2 fast  |0 (OCoLC)fst00952647 
650 1 7 |a Céphalées  |x traitement médicamenteux.  |2 fmesh 
650 2 7 |a Céphalées  |x prévention et contrôle.  |2 fmesh 
650 7 |a Migraine  |x Chimiothérapie.  |2 ram 
650 7 |a Analgésiques.  |2 ram 
700 1 |a Olesen, Jes. 
700 1 |a Ramadan, Nabih. 
776 0 8 |i Print version:  |t Innovative drug development for headache disorders.  |d Oxford ; New York : Oxford University Press, 2008  |z 9780199552764  |w (DLC) 2008021573  |w (OCoLC)228569514 
830 0 |a Frontiers in headache research ;  |v v. 16. 
856 4 0 |u https://ebsco.uam.elogim.com/login.aspx?direct=true&scope=site&db=nlebk&AN=467641  |z Texto completo 
938 |a ProQuest Ebook Central  |b EBLB  |n EBL975568 
938 |a ebrary  |b EBRY  |n ebr10581488 
938 |a EBSCOhost  |b EBSC  |n 467641 
938 |a ProQuest MyiLibrary Digital eBook Collection  |b IDEB  |n 389289 
938 |a Oxford University Press USA  |b OUPR  |n EDZ0000128737 
938 |a YBP Library Services  |b YANK  |n 9316015 
938 |a YBP Library Services  |b YANK  |n 12890334 
938 |a Internet Archive  |b INAR  |n innovativedrugde0000unse 
994 |a 92  |b IZTAP